There could also be nothing in there at all and all we get is,
This page has been intentionally left blank.
Is that an oxymoron? How can it be blank when you have printed that on it.:)
Printable View
I bought a few in today. First time for weeks. If you think the future of this company hinges on next weeks report, get out and put your funds into treasuries
So true.
If anyone is interested, have passed on cxbladder to another friend of mine who passed it onto his friend who works in primary care as a GP has never heard of cxbladder as well.... In a multicdisciplinary clinic not a sole practitioner clinic....
Don't know what the interest is like in the states, but I think anything between 1000 - 2000 sales is probably more realistic for this report...
UrologyCare Wellington use CXBladder http://www.urologycarewellington.co.nz/news.html
And this guy is still in remission! Wahoo! http://bladdercancerfight.blogspot.c...oundup-of.html
PS Edit - who could forget last October when first US sales occurred... http://www.biospectrumasia.com/biosp...r#.U3yapNKSyDg
Be excited. BE. BE, EXCITED.
This from a recent Otago University Enews FYI;
Congratulations to Pacific Edge! It's been a stellar twelve months of remarkable achievements for the Dunedin-based company, and there is plenty to celebrate.
In 2013 and 2014 Pacific Edge:
- Launched Cxbladder, a potentially life-saving bladder cancer test that, unlike other tests on the market, is non-invasive, fast, accessible, inexpensive and extremely accurate.
- Won the NZ Innovation Council's Supreme Innovator Award.
- Were named Business of the Year by the Otago Daily Times.
- Opened a custom-built laboratory in Pennsylvania, USA, which has capacity to process 4,000 Cxbladder tests per week.
- Achieved CLIA (Clinical Laboratory Improvements Amendments) accreditation for both its US and Dunedin based laboratories.
- Achieved NZ DHB support to fast-track the introduction of Cxbladder tests to the four main DHB boards.
- Signed agreements with three National Provider Networks in USA and started commercial sales in the giant American healthcare market.
- Skyrocketed up the stock market and will soon join the NZX50.
Pacific Edge formed in 2001 to commercialise world-leading cancer genetics research from the University. Cxbladder is a new, non-invasive, urine based bladder cancer detection test that measures the expression of five genes that create a unique molecular signature for bladder cancer, alerting doctors to possible tumours or helping to rule out the presence of cancer in patients. More accurate than many other urine-based cancer detection tests, Cxbladder can give patients and doctors added confidence in their diagnoses quickly and cost effectively.
Pacific Edge aims to launch two more unique products soon ..
Now look here you two (Robbo & Left Field)...you need to stop ramping up this stock. You have been warned before (on numerous occasions) and it is just not good enough. For goodness sake, if you carry on like this there may one or two out there that actually want to purchase this stock and god, if that happens it may force the price back up to the dizzy level of $1.05. And if that happens, the big seller waiting in the wings - who obviously sees no benefit in holding PEB shares - well, they will just have to keep selling to get the price back down .......
The question is....where will the SP be at the close of play next Thursday? And then, where will it be at the close next Friday........ Can hardly wait.
Just a disclosure as well (which the article probably should have done - I received it too as a once upon a time ex-student), the University holds a LOT of PEB shares.
I was talking to the vice chancellor a couple of months ago and she said that PEB was always really accomodating when they wanted to wheel international visitors through the labs, and that having the labs on campus had been massively mutually beneficial to both parties.
Seems like the Uni is helping with the exposure side of things also :)